Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences

SILVER SPRING, Md., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the company will participate in two upcoming virtual investor conferences.

Event: Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services ForumFormat: 1x1 MeetingsDate: Thursday, November 18, 2021

Event: 33rd Annual Piper Sandler Healthcare Conference Format: Fireside Chat and 1x1 meetingsDate: Members of the management team will be participating in investor meetings on Thursday, December 2, 2021. A pre-recorded Fireside Chat will be available beginning Monday, November 22nd at 7:00AM PT / 10:00AM ET on the “Investors” section of the Company’s website at www.Aziyo.com.

About Aziyo Biologics Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.        

Media:Courtney GuyerAziyo Biologics, Inc.[email protected]

Investors:Leigh Salvo Gilmartin Group[email protected]

You May Also Be Interested In

• Cerebras Unveils CS-4: Up to 30 Times Faster than GPU-based Solutions
• CARsgen Therapeutics Announces 2026 Interim Results
• American Fusion Inc. (OTC: AMFN) Receives FINRA Clearance of Form 211 Under SEC Rule 15c2-11